Blog

Hospira wins French biosimilar drug tender at 45 percent discount

PARIS (Reuters) – A major French hospital group has chosen a cheap copycat version of a top-selling drug for treating its patients with rheumatoid arthritis and Crohn’s disease in a victory for a new type of medicine known as biosimilars.    In a document seen by Reuters, the central purchasing agency for the Assistance Publique – Hôpitaux de Paris (AP-HP) said on Friday it had decided to buy the biosimilar version